Application 091634
- Type
- ANDA
- Sponsor
- GLENMARK GENERICS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ALYACEN 1/35 | ETHINYL ESTRADIOL; NORETHINDRONE | TABLET;ORAL-28 | 0.035MG;1MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A091634-001 | ALYACEN 1/35 | ETHINYL ESTRADIOL; NORETHINDRONE | 0.035MG;1MG | TABLET / ORAL-28 | AB | 2012-01-19 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A091634-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A091634-001 | ALYACEN 1/35 | 0.035MG;1MG | TABLET / ORAL-28 | AB | 2012-01-19 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A091634-001 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ALYACEN 1/35 | NORETHINDRONE AND ETHINYL ESTRADIOL | Glenmark Pharmaceuticals Inc., USA | 5c02b4d3-1e2f-439a-ae45-02304ee190d1 | 2026-01-31 | Warnings, Adverse reactions | 091634 ANDA091634 68462-394 |
| ALYACEN 1/35 | NORETHINDRONE AND ETHINYL ESTRADIOL | Proficient Rx LP | fa32e05b-c86d-4743-aee5-be3fc515152b | 2026-01-01 | Warnings, Adverse reactions | 091634 ANDA091634 71205-547 |
| ALYACEN 1/35 | NORETHINDRONE AND ETHINYL ESTRADIOL | A-S Medication Solutions | a45ee86e-69ca-49a5-8990-5dde52d4a522 | 2024-05-07 | Warnings, Adverse reactions | 091634 ANDA091634 50090-1477 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 50090-1477 | ALYACEN 1/35 | norethindrone and ethinyl estradiol | A-S Medication Solutions | ANDA | Current |
| 50090-1477 | ALYACEN 1/35 | norethindrone and ethinyl estradiol | A-S Medication Solutions | ANDA | Current |
| 53002-1780 | ALYACEN 1/35 | norethindrone and ethinyl estradiol | RPK Pharmaceuticals, Inc. | ANDA | Current |
| 68462-394 | ALYACEN 1/35 | norethindrone and ethinyl estradiol | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 70518-1212 | ALYACEN 1/35 | norethindrone and ethinyl estradiol | REMEDYREPACK INC. | ANDA | Current |
| 71205-547 | ALYACEN 1/35 | norethindrone and ethinyl estradiol | Proficient Rx LP | ANDA | Current |